OSA UK health economics report
Our OSA health economics report discovered significant savings could be made for the NHS through greater OSA awareness and treatment.
Around 667,000 (45 per cent) of the 1.5 million people estimated to be living with OSA in the UK have the moderate to severe forms of the disorder.
However, fewer than half of these (around 330,000) are currently receiving the treatment they need, leaving the remainder with increased risk of extreme daytime sleepiness and serious health conditions linked to OSA, such as stroke, diabetes and cardiovascular disease.
The research concludes that improving public awareness of the signs and symptoms of OSA, as well as improving access to the specialist sleep services required to diagnose and treat OSA, could result in significant savings to UK health services, and significant improvements to road safety.
The economic consequences of treating OSA in the UK
We presented a poster summarising the key findings of our research at the Association for Respiratory Technology and Physiology (ARTP) conference in 2015.